% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@ARTICLE{Herrmann:132816,
      author       = {W. J. Herrmann and C. Weikert and M. Bergmann and H. Boeing
                      and V. Katzke$^*$ and R. Kaaks$^*$ and D. Tiller and K. H.
                      Greiser and M. Heier and C. Meisinger and C. O. Schmidt and
                      H. Neuhauser and C. Heidemann and C. Jünger and P. S. Wild
                      and S. H. Schramm and K.-H. Jöckel and M. Dörr and T.
                      Pischon},
      title        = {[{A}ssessing incident cardiovascular and metabolic diseases
                      in epidemiological cohort studies in {G}ermany].},
      journal      = {Bundesgesundheitsblatt, Gesundheitsforschung,
                      Gesundheitsschutz},
      volume       = {61},
      number       = {4},
      issn         = {1437-1588},
      address      = {Berlin},
      publisher    = {Springer},
      reportid     = {DKFZ-2018-00460},
      pages        = {420 - 431},
      year         = {2018},
      abstract     = {Cardiovascular and metabolic diseases are a major cause of
                      mortality and loss of quality of life in Germany. Research
                      into risk factors of these diseases requires large
                      population-based cohort studies. Complete and accurate
                      assessment of the incidence of cardiovascular and metabolic
                      diseases is a key element for valid interpretation of the
                      results from such studies.Our aim was to identify
                      population-based cohort studies with incidence of
                      cardiovascular and metabolic diseases in Germany and to
                      summarize their methods for assessment and classification of
                      disease endpoints, including myocardial infarction, type 2
                      diabetes, stroke, heart failure, and arterial
                      hypertension.Within the framework of a workshop,
                      representatives of the ascertained population-based cohort
                      studies in Germany with incidence of cardiovascular or
                      metabolic diseases were invited to present and to
                      systematically provide information on their methods of
                      endpoint identification.We identified eight studies from
                      different regions in Germany with a total of 100,571
                      participants, aged 18-83 years at baseline. Self-reporting
                      by study participants is the major source for further
                      inquiries to assess disease endpoints in these studies. Most
                      studies use additional data sources to verify the incidence
                      of diseases, such as documents provided by the treating
                      physician or hospital.Our results highlight the central role
                      of self-reporting and the efforts associated with
                      identification and verification of disease endpoints in
                      cohort studies. They also provide a basis for future
                      population-based studies that aim for standardized
                      assessment of the incidence of cardiovascular and metabolic
                      diseases.},
      cin          = {C020},
      ddc          = {610},
      cid          = {I:(DE-He78)C020-20160331},
      pnm          = {323 - Metabolic Dysfunction as Risk Factor (POF3-323)},
      pid          = {G:(DE-HGF)POF3-323},
      typ          = {PUB:(DE-HGF)16},
      pubmed       = {pmid:29487975},
      doi          = {10.1007/s00103-018-2712-4},
      url          = {https://inrepo02.dkfz.de/record/132816},
}